4/19/2024 | SP | New Issue: RBC prices $900,000 autocallable contingent coupon barrier notes on two stocks
|
4/7/2024 | SP | New Issue: BMO prices $713,000 autocallable barrier notes with contingent coupons on stock basket
|
3/14/2024 | SP | New Issue: Bank of Montreal prices $50,000 buffer enhanced return notes linked to 10 stocks
|
3/14/2024 | SP | New Issue: BMO prices $1,000 autocallable barrier notes with contingent coupons on stock basket
|
3/14/2024 | SP | New Issue: BMO prices $200,000 buffer enhanced return notes linked to stock basket
|
3/14/2024 | SP | New Issue: BMO prices $7,000 market-linked notes on stock basket
|
3/12/2024 | SP | New Issue: BMO prices $1,000 buffer enhanced return notes linked to stock basket
|
2/2/2024 | SP | New Issue: BMO sells $1.7 million callable barrier notes with contingent coupons on Edwards
|
8/28/2023 | SP | New Issue: JPMorgan prices $749,000 10% autocallable contingent interest notes linked to Edwards
|
8/18/2023 | SP | New Issue: Citi prices $2.14 million 10.35% autocallable equity linked securities on three stocks
|
8/7/2023 | SP | New Issue: BMO prices $10,000 market-linked notes tied to stock basket
|
12/9/2022 | SP | New Issue: UBS prices $2.37 million trigger callable contingent yield notes on Edwards Lifesciences
|
7/21/2022 | BK | Edwards Lifesciences refinances with $750 million five-year revolver
|
5/2/2021 | SP | New Issue: GS Finance sells $520,000 leveraged notes on basket of 82 stocks
|
2/22/2021 | SP | New Issue: GS Finance sells $5 million leveraged notes on basket of 78 stocks
|
2/17/2021 | SP | New Issue: Credit Suisse sells $711,000 contingent coupon autocallable reverse converts on stocks
|
10/11/2020 | SP | New Issue: Scotia sells $3.29 million capped enhanced participation notes on basket of 79 stocks
|
9/15/2020 | SP | New Issue: GS Finance sells $6.83 million leveraged basket-linked notes on 60 stocks
|
6/18/2020 | SP | New Issue: Goldman prices $7.88 million leveraged basket-linked notes on 62 stocks
|
9/17/2019 | BKIG | S&P ups Edwards Lifesciences
|
3/25/2019 | BKIG | S&P lifts Edwards view to positive
|
6/7/2018 | BKIG | S&P gives Edwards Lifesciences notes BBB-
|
6/6/2018 | IG | Market Commentary: Credit Suisse, Compass Bank, KeyBank, Western Union price; supply beats weekly forecast
|
6/6/2018 | EMHYPFPV | Market Commentary: Credit Suisse, Compass Bank, KeyBank, Western Union price; supply beats weekly forecast
|
6/6/2018 | IG | New Issue: Edwards Lifesciences sells $600 million 4.3% 10-year notes at 135 bps over Treasuries
|
6/6/2018 | IG | Market Commentary: Morning Commentary: High-grade supply surpasses weekly forecast; Western Union, KfW offer notes
|
6/6/2018 | IG | Edwards Lifesciences to sell senior notes via six bookrunners
|
5/1/2018 | BKIG | S&P rates Edwards Lifesciences revolver BBB-
|
4/30/2018 | BK | Edwards Lifesciences gets $750 million five-year replacement revolver
|
1/16/2018 | BKIG | Moody’s ups Edwards Lifesciences to Baa2
|
11/3/2016 | SP | New Issue: JPMorgan prices $6.6 million return notes linked to basket of 50 stocks
|
10/26/2016 | SP | JPMorgan plans one-year return notes linked to basket of 50 stocks
|
11/10/2014 | BKIG | S&P rates Edwards Lifesciences loan BBB-
|
7/24/2014 | BK | Edwards Lifesciences gets $750 million five-year revolver
|
9/24/2013 | IG | Market Commentary: Flow of deals continues as Edwards, TVA, Liberty price; Marriott, Marsh & McLennan notes firm
|
9/24/2013 | BK | Edwards Lifesciences to repay revolver via new notes offering proceeds
|
9/24/2013 | BKIG | S&P rates Edwards Lifesciences notes BBB-
|
9/24/2013 | BKIG | Moody's rates Edwards notes Baa3
|
9/24/2013 | IG | Edwards Lifesciences intends to sell senior notes due 2018
|
9/24/2013 | IG | New Issue: Edwards Lifesciences sells $600 million 2.875% five-year notes at 157 bps spread
|
9/6/2013 | BK | S&P rates Edwards Lifesciences BBB-
|
6/18/2013 | BK | Edwards Lifesciences lifts four-year credit facility to $750 million
|
5/17/2013 | PP | Edwards Lifesciences completes $5 million private placement of shares
|
11/26/2008 | CVHY | Edwards LifeSciences files automatic shelf registration
|
7/23/2008 | CV | Edwards Lifesciences redeems all $150 million convertible debentures
|
10/19/2006 | BT | Edwards Lifesciences reports $15.3 million of cash, tightens 2006 EPS guidance
|
7/24/2006 | BT | Edwards Lifesciences says Q2 net income up 260% on sales of $267.3 million
|
5/30/2006 | BT | Edwards gets FDA approval to expand heart valve trial
|
5/11/2006 | BT | Edwards Lifesciences announces approval of new stock repurchase program
|
3/1/2006 | BT | Edwards Lifesciences breaks ground on heart valve manufacturing facility in Singapore
|
1/25/2006 | BT | Edwards Lifesciences' FloTrac sensor approved in Japan
|
1/23/2006 | BT | Edwards Lifesciences, Medtronic settle patent infringement lawsuit
|
12/1/2005 | BT | Edwards to restart heart valve study with new delivery system
|
11/3/2005 | BT | Angiotech to acquire vascular graft product line from Edwards Lifesciences for $14 million
|
9/14/2005 | BT | Edwards Lifesciences' board approves stock repurchase program, $15 million donation
|
6/14/2005 | BT | Edwards Lifesciences cut by First Albany
|
5/20/2003 | CV | Edwards Lifesciences says greenshoe exercised, raising convertibles to $150 million
|
5/6/2003 | CV | New Issue: Edwards LifeSciences $125 million convertibles yield 3.875%, up 90%
|
5/6/2003 | CV | Market Commentary: Market mixed in choppy trade; new deal surge continues
|
5/5/2003 | CV | Edwards Lifesciences $125 million convertibles talked to yield 3.375-3.875%, up 90-95%
|
5/5/2003 | CV | Market Commentary: Tech names higher, partly on Lucent/Juniper agreement; LIN, Edwards pricing before Tuesday open
|